Dr. Grace R. Tarabay
Overview
Grace R. Tarabay-Caridad, MD, is a medical oncologist at UPMC Hillman Cancer Center, Beaver. Board-certified in internal medicine, oncology, and hematology, Dr. Tarabay-Caridad received her medical degree from American University of Beirut Medical Center in Beiruit, Lebanon. She completed her fellowship at St. Vincent;s Comprehensive Cancer Center in New York and her residency at Staten Island University Hospital in New York.
Dr. Tarabay is highly rated in 37 conditions, according to our data. Her top areas of expertise are Budd-Chiari Syndrome, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Bone Marrow Aspiration.
Her clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1030 Beaner Hollow Road, Beaver, PA 15009
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Frequently Asked Questions about Dr. Grace R. Tarabay
How do I make an appointment with Dr. Grace R. Tarabay?
You can book an appointment with Dr. Grace R. Tarabay by calling their office at 724-774-0778. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Grace R. Tarabay a top-rated expert for Budd-Chiari Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Grace R. Tarabay is classified as an Distinguished expert for Budd-Chiari Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Grace R. Tarabay specialize in?
While Dr. Grace R. Tarabay is a Hematology Oncology, they have specific expertise in Budd-Chiari Syndrome, Inflammatory Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Grace R. Tarabay accept my insurance?
Dr. Grace R. Tarabay accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 724-774-0778 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Tarabay isDistinguished. Learn about Angiosarcoma.
- Budd-Chiari SyndromeDr. Tarabay isDistinguished. Learn about Budd-Chiari Syndrome.
- Inflammatory Breast CancerDr. Tarabay isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Tarabay isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AgranulocytosisDr. Tarabay isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Tarabay isAdvanced. Learn about Anemia.
- Breast CancerDr. Tarabay isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Tarabay isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Tarabay isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Acute Eosinophilic PneumoniaDr. Tarabay isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Tarabay isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Tarabay isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Tarabay isExperienced. Learn about Acute Promyelocytic Leukemia.